Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
Top Cited Papers
- 1 April 2008
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 7 (4) , 302-311
- https://doi.org/10.1016/j.cmet.2008.03.003
Abstract
No abstract availableKeywords
Funding Information
- Ono Medical Research Foundation
- Suzuken Memorial Foundation (17790079)
- Takeda Science Foundation
- National Cancer Institute
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 39 references indexed in Scilit:
- Gut Microbes May Affect ObesityGastroenterology, 2007
- Pioglitazone Trial for NASH: Results Show PromiseGastroenterology, 2007
- Ligand-activated PPARβ efficiently represses the induction of LXR-dependent promoter activity through competition with RXRMolecular and Cellular Endocrinology, 2006
- Increased expression of PPARγ in high fat diet-induced liver steatosis in miceBiochemical and Biophysical Research Communications, 2005
- The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined dietHepatology Research, 2005
- PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytesAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- CIDE-A, a novel link between brown adipose tissue and obesityTrends in Molecular Medicine, 2004
- Separation of Retinoid X Receptor Homo- and Heterodimerization FunctionsMolecular and Cellular Biology, 2003
- Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinedionesPublished by Elsevier ,2001
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994